Pre-Surgical Risk Stratification

Multidisciplinary Clearance: RCRI, METs, ASA, STOP-BANG, Caprini VTE
How This Tool Works: Enter the patient's data once. The engine automatically populates derived fields (BMI, CrCl, STOP-BANG demographics, Caprini age brackets, RCRI renal/surgical criteria) and synthesises six validated perioperative scores into a single composite verdict with specialist-specific action plans. Fields marked are auto-calculated from your entries above.

1. Surgical Urgency & Active Cardiac Conditions

2. Demographics & Vitals

3. Planned Procedure & Surgical Risk Grade

4. Functional Capacity (METs Assessment)

5. Revised Cardiac Risk Index (Lee / RCRI)

6. ASA Physical Status Classification

7. Airway Assessment

8. STOP-BANG Questionnaire (OSA Screen)

9. Caprini VTE Risk Assessment (Simplified)

10. Comorbidities & Critical Medications

Perioperative Risk: A Multidisciplinary Framework

The CARP Trial Principle: Preoperative coronary revascularisation (PCI or CABG) does NOT improve perioperative outcomes unless the patient independently qualifies for it outside the surgical context (McFalls et al., NEJM 2004). Testing should only be pursued if the result would change perioperative management.

1. ACC/AHA Stepwise Algorithm (Cardiology)

Step 1: Is surgery emergent? If yes, proceed to OT. No further testing changes management.

Step 2: Active Cardiac Condition (ACS, decompensated HF, significant arrhythmia, severe valvular disease)? If yes, delay surgery and obtain cardiology consultation.

Step 3: Low-risk surgery (<1% MACE)? If yes, proceed without further cardiac testing.

Step 4: Adequate functional capacity (≥4 METs) without symptoms? If yes, proceed without further testing.

Step 5: Poor/unknown functional capacity: use RCRI. RCRI 0-1 = proceed. RCRI ≥2 = consider pharmacological stress testing ONLY if it will change management.

2. The 4-MET Question (Physician's Bedside Tool)

Pathophysiology: 1 MET = 3.5 mL O2/kg/min. Surgery imposes 4-6 METs of stress. If a patient cannot achieve 4 METs, their cardiopulmonary reserve cannot tolerate surgical stress. This single bedside question has superior predictive value to most laboratory tests.

Bedside Pearl: "Can you climb one flight of stairs without stopping?" or "Can you walk 500 metres on flat ground without breathlessness?" If yes, functional capacity is likely ≥4 METs.

3. RCRI (Lee Index, 1999)

Score: 0 = 3.9% MACE; 1 = 6.0%; 2 = 10.1%; 3+ = 15%+. The critical threshold is 2: RCRI ≥2 with poor functional capacity triggers the decision for non-invasive stress testing.

Indian Context: South Asian patients may carry higher baseline cardiovascular risk due to the "thin-fat" Indian phenotype (visceral adiposity with normal BMI), higher insulin resistance, and earlier-onset CAD. Yaddanapudi et al. recommend a lower threshold for cardiac evaluation in Indian patients with metabolic syndrome even when RCRI appears reassuring.

4. STOP-BANG and Non-Obese OSA

Score: 0-2 = Low; 3-4 = Intermediate; 5-8 = High risk for OSA. Score ≥3 mandates postoperative continuous pulse oximetry and caution with opioid analgesia.

Non-Obese OSA Pearl: STOP-BANG was validated in predominantly obese Western populations. In non-obese or underweight elderly patients (common in India), a score of 3-4 driven solely by age + gender + hypertension has lower specificity for obstructive sleep apnoea. Consider central sleep apnoea or upper-airway anatomical factors rather than classic obesity-driven OSA. Clinical correlation is essential.

5. Caprini VTE and Indian Context

Pathophysiology (Virchow's Triad): Surgery activates all three arms: endothelial injury, stasis, and hypercoagulability. VTE is the most preventable cause of in-hospital death.

Indian Data: The ASI guidelines recommend pharmacological thromboprophylaxis for Caprini ≥3. While historically VTE was considered less common in Indians, recent data from Agarwala et al. show comparable VTE incidence when systematically screened, and under-prophylaxis remains a concern.

6. Medication Reconciliation: The Details That Save Lives

CONTINUE: Beta-blockers, statins, thyroid replacement, antiepileptics, inhaled bronchodilators.

HOLD: ACEi/ARBs (morning of surgery), metformin (24-48 hrs), SGLT2 inhibitors (3 days, euglycaemic DKA risk), oral hypoglycaemics (morning of surgery).

DAPT and Stents: BMS: defer elective surgery ≥30 days. DES: defer 6-12 months. Premature DAPT discontinuation causes stent thrombosis with >30% mortality.

Neuraxial + Anticoagulation: Epidural haematoma risk. Warfarin must have INR <1.5. LMWH: last dose ≥12 hrs (prophylactic) or ≥24 hrs (therapeutic) before neuraxial block.

Stress-Dose Steroids: Patients on ≥5 mg prednisone daily for ≥3 weeks need hydrocortisone 50-100 mg IV at induction.

7. Prehabilitation Checklist

Smoking: Cessation ≥4 weeks preop reduces pulmonary complications by 30-40%.

Glycaemic Control: HbA1c >8% = 2-3x higher SSI. Target perioperative glucose 140-180 mg/dL (NICE-SUGAR).

Anaemia: Hb <10 g/dL independently increases 30-day mortality. IV iron infusion 2-4 weeks preop can restore Hb. Particularly relevant in India where nutritional anaemia is highly prevalent.

Abbreviations: RCRI (Revised Cardiac Risk Index) · METs (Metabolic Equivalents) · ASA (American Society of Anesthesiologists) · MACE (Major Adverse Cardiac Events) · OSA (Obstructive Sleep Apnoea) · VTE (Venous Thromboembolism) · DAPT (Dual Antiplatelet Therapy) · DOAC (Direct Oral Anticoagulant) · CrCl (Creatinine Clearance) · OT (Operating Theatre) · HDU (High Dependency Unit)
Algorithm References & Evidence Base
  1. Fleisher LA, et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation. Circulation. 2014;130(24):e199-e267.
  2. Lee TH, et al. Derivation and Validation of a Simple Index for Cardiac Risk. Circulation. 1999;100(10):1043-1049.
  3. Chung F, et al. STOP-Bang Questionnaire. Chest. 2016;149(3):631-638.
  4. Caprini JA. Thrombosis Risk Assessment. Disease-a-Month. 2005;51(2-3):70-78.
  5. McFalls EO, et al. CARP Trial. N Engl J Med. 2004;351(27):2795-2804.
  6. Kristensen SD, et al. 2014 ESC/ESA Guidelines on Non-Cardiac Surgery. Eur Heart J. 2014;35(35):2383-2431.
  7. NICE-SUGAR Study Investigators. N Engl J Med. 2009;360(13):1283-1297.
  8. Yaddanapudi LN. Perioperative Cardiovascular Evaluation for Non-Cardiac Surgery. Indian J Anaesth. 2015;59(2):106-113.
  9. Agarwala S, et al. VTE Prophylaxis in Surgical Patients: Practice Survey from India. Indian J Surg. 2018;80(6):575-581.
  10. Duceppe E, et al. Canadian CCS Guidelines on Perioperative Cardiac Risk. Can J Cardiol. 2017;33(1):17-32.
How to Cite This Tool

AMA Style:
Umakanth S. Pre-Surgical Risk Stratification Engine. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. Pre-Surgical Risk Stratification Engine [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

Category Risk Stratification & Diagnostic Algorithms
Specialties Internal Medicine, Cardiology, Surgery, Anaesthesiology
Status New Pathway